Strategic investment strengthens global molecular biology partnership

Integra Biosciences has acquired shares in CleanNA, deepening their long-term collaboration and expanding CleanNA’s global presence in molecular biology.

CleanNA, a Netherlands-based specialist in magnetic bead-based DNA/RNA extraction kits, complements Integra’s liquid handling and automation portfolio. The partnership initially focused on private-label distribution of SPRI MAGFLO™ beads for NGS size selection and PCR purification. Integra’s investment now positions the companies to expand integrated solutions for NGS library preparation and automated workflows.

Urs Hartmann, CEO of Integra Biosciences, said: “CleanNA’s innovative capabilities align perfectly with our vision for efficient, automated lab solutions. This investment underlines our commitment to long-term growth and supporting CleanNA in developing new applications and reaching broader markets.”

Glenn Nohar, CEO of CleanNA, added: “The strategic alignment and shared mission with Integra make this an exciting step for growth. Their global network enables us to bring our magnetic bead technology to more researchers worldwide.”

By joining forces, the two companies now offer a comprehensive range of bead-based solutions, from reagents and consumables to automation modules, strengthening their position in the molecular biology market.